Articles From: Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients to Arthur J. Gallagher & Co. Acquires The Forker Company


Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for ARC-520, it’s drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.
Sign-up for Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that initial data from the ongoing Phase 2a study of ARC-520, its RNAi therapeutic candidate for the treatment of chronic hepatitis B (HBV) infection, was presented today in the late-breaking poster session at the 2014 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Boston.
Sign-up for Arrowhead Presents Data on ARC-520 and ARC-AAT at AASLD The Liver Meeting® 2014 investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company in a preliminary call of a partial clinical hold, under which the Company is cleared to begin a modified multiple-dose study of ARC-520 in patients with chronic hepatitis B infection.
Sign-up for Arrowhead Provides Update on IND for ARC-520 Phase 2b Study investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced financial results for its fiscal 2014 fourth quarter and year ended September 30, 2014.
Sign-up for Arrowhead Reports Fiscal 2014 Year End Financial Results investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the Company will present at upcoming investor and scientific conferences.
Sign-up for Arrowhead to Present at Upcoming Conferences investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will report its financial results for the fiscal 2014 fourth quarter and year ended September 30, 2014, on Tuesday, November 25, 2014, at 4:30 p.m. EST.
Sign-up for Arrowhead to Report Fiscal 2014 Fourth Quarter and Year End Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986845001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Announces Q4 2014 Estimated Production and 2015 Guidance investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977057001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Energy Inc. Announces 2014 Third Quarter Results and Declares Quarterly Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986358001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Energy Inc. Announces Trading of Common Shares in the U.S. on OTCQX(R) Under the Symbol AEYIF investment picks
Conference Call Scheduled For Tuesday, January 27th, 2015 at 10:00 AM CT ARMSTRONG, Iowa , Jan.
Sign-up for Art's Way Manufacturing Announces Conference Call To Review 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983336001&sourceType=1 http://media3.marketwire.com/docs/arteklogoLG.png CALGARY, ALBERTA --
Sign-up for Artek Exploration Ltd. Announces Closing of Non-Core Property Dispositions investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982275001&sourceType=1 http://media3.marketwire.com/docs/arteklogoLG.png CALGARY, ALBERTA --
Sign-up for Artek Exploration Ltd. Announces Non-Core Property Dispositions investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978700001&sourceType=1 http://media3.marketwire.com/docs/arteklogoLG.png CALGARY, ALBERTA --
Sign-up for Artek Exploration Ltd. Announces Third Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0988016001&sourceType=1 http://media3.marketwire.com/docs/arteklogoLG.png CALGARY, ALBERTA --
Sign-up for Artek Exploration Ltd. Provides Operations Update investment picks
2015/1/2
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986171001&sourceType=1 TORONTO, ONTARIO --
Sign-up for Artemis U.S. Capital Appreciation Fund Announces Annual Redemption Price investment picks
2015/1/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986709001&sourceType=1 TORONTO, ONTARIO --
Sign-up for Artemis U.S. Capital Appreciation Fund Announces Fund Termination investment picks
NEWARK, Del., Oct.
Sign-up for Artesian Resources Annual Charity Golf Outing Benefits Local Organizations investment picks
NEWARK, Del., Nov.
Sign-up for Artesian Resources Corporation Reports Third Quarter 2014 Results investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires Affinity Marketing Group investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires Blue Holdings Pty Ltd investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires e3 Financial investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires Instrat Insurance Brokers investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires Insurance Associates, Inc. investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires O'Gorman & Young, Incorporated investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires SGB-NIA Insurance Brokers investment picks
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires The Forker Company investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients to Arthur J. Gallagher & Co. Acquires The Forker Company
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent